Twist Bioscience's Fiscal Q1 Loss Narrows, Revenue Rises; Fiscal 2025 Sales Guidance Lifted

MT Newswires Live

Feb 03

Twist Bioscience (TWST) reported a fiscal Q1 loss Monday of $0.53 per diluted share, narrower than a loss of $0.75 a year earlier.

Analysts polled by FactSet expected a loss of $0.68.

Revenue for the quarter ended Dec. 31 was $88.7 million, compared with $71.5 million a year earlier.

Analysts surveyed by FactSet expected $87 million.

The company said it expects fiscal Q2 revenue of $91 million to $93 million.

Analysts polled by FactSet expect $90.9 million.

For fiscal 2025, Twist Bioscience raised its revenue guidance to $372 million to $379 million, compared with its previous guidance range of $367 million to $377 million.

Analysts polled by FactSet expect 373.3 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2508117922"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2508117922\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2508117922?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-03 20:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2508117922","market":"hk","top_or_hot":-1,"title":"Twist Bioscience's Fiscal Q1 Loss Narrows, Revenue Rises; Fiscal 2025 Sales Guidance Lifted","media":"MT Newswires Live","content":"<html><body><p> Twist Bioscience (TWST) reported a fiscal Q1 loss Monday of $0.53 per diluted share, narrower than a loss of $0.75 a year earlier.</p><p>Analysts polled by FactSet expected a loss of $0.68.</p><p>Revenue for the quarter ended Dec. 31 was $88.7 million, compared with $71.5 million a year earlier.</p><p>Analysts surveyed by FactSet expected $87 million.</p><p>The company said it expects fiscal Q2 revenue of $91 million to $93 million.</p><p>Analysts polled by FactSet expect $90.9 million.</p><p>For fiscal 2025, Twist Bioscience raised its revenue guidance to $372 million to $379 million, compared with its previous guidance range of $367 million to $377 million.</p><p>Analysts polled by FactSet expect 373.3 million.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Twist Bioscience's Fiscal Q1 Loss Narrows, Revenue Rises; Fiscal 2025 Sales Guidance Lifted</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTwist Bioscience's Fiscal Q1 Loss Narrows, Revenue Rises; Fiscal 2025 Sales Guidance Lifted\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-03 20:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Twist Bioscience (TWST) reported a fiscal Q1 loss Monday of $0.53 per diluted share, narrower than a loss of $0.75 a year earlier.</p><p>Analysts polled by FactSet expected a loss of $0.68.</p><p>Revenue for the quarter ended Dec. 31 was $88.7 million, compared with $71.5 million a year earlier.</p><p>Analysts surveyed by FactSet expected $87 million.</p><p>The company said it expects fiscal Q2 revenue of $91 million to $93 million.</p><p>Analysts polled by FactSet expect $90.9 million.</p><p>For fiscal 2025, Twist Bioscience raised its revenue guidance to $372 million to $379 million, compared with its previous guidance range of $367 million to $377 million.</p><p>Analysts polled by FactSet expect 373.3 million.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2508117922","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2508117922","pubTimestamp":1738586033,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Twist Bioscience  reported a fiscal Q1 loss Monday of $0.53 per diluted share, narrower than a loss of $0.75 a year earlier.Analysts polled by FactSet expected a loss of $0.68.Revenue for the quarter ended Dec. 31 was $88.7 million, compared with $71.5 million a year earlier.Analysts surveyed by FactSet expected $87 million.The company said it expects fiscal Q2 revenue of $91 million to $93 million.Analysts polled by FactSet expect $90.9 million.For fiscal 2025, Twist Bioscience raised its revenue guidance to $372 million to $379 million, compared with its previous guidance range of $367 million to $377 million.Analysts polled by FactSet expect 373.3 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"Twist Bioscience第一财季亏损收窄，收入增长；2025财年销售指引上调","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":0.9},"content_text":"Twist Bioscience (TWST) reported a fiscal Q1 loss Monday of $0.53 per diluted share, narrower than a loss of $0.75 a year earlier.Analysts polled by FactSet expected a loss of $0.68.Revenue for the quarter ended Dec. 31 was $88.7 million, compared with $71.5 million a year earlier.Analysts surveyed by FactSet expected $87 million.The company said it expects fiscal Q2 revenue of $91 million to $93 million.Analysts polled by FactSet expect $90.9 million.For fiscal 2025, Twist Bioscience raised its revenue guidance to $372 million to $379 million, compared with its previous guidance range of $367 million to $377 million.Analysts polled by FactSet expect 373.3 million.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}